跳至主要内容
临床试验/IRCT2014121420086N2
IRCT2014121420086N2已完成2 期

Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinaemia

Shahid sdoughi university of medical sciences0 个研究点目标入组 110 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 35 years(—)
性别
Female

入选标准

  • 110 PCOS women with increased serum prolactin concentration [1.5 fold more than normal level (>37.5ng/ml)]; between 18-35 years old, who referred to endocrinology clinic of Khatamal Anbiaa Cilinic, Shahid Sadoughi University of Medical Sciences, were examined for other causes of increased prolactin levels such as TSH test, hypophis MRI for detection of prolactinema and other disorders or tumors that can increase prolactin, and then women who had diagnosed as PCOS according to the latest AES standards enrolled in the study. Patients who had other endocrine disorders (such as thyroid disorders), history of cardiovascular disease, history of using the increasing prolactin drugs, women who wanted to be pregnant, and who couldn’t tolerate the cabergoline were excluded from the study.

排除标准

  • 未提供

研究者

发起方
Shahid sdoughi university of medical sciences

相似试验